Nurse Practitioner in Pleasant Hill, OR Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Ms. Mary L Fey, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 35859 Highway 58, Pleasant Hill, OR 97455 Phone: 541-767-5200 Fax: 541-937-1370 |
Ms. Susan Cox Hammond, RN/FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 85226 Marriott Ln, Pleasant Hill, OR 97455 Phone: 541-741-4181 Fax: 541-741-6838 |
Ms. Julie Bryce Willardson, DNP, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 83960 Spring Hill Ln, Pleasant Hill, OR 97455 Phone: 541-819-0575 |
Melissa Rice, APRN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 35859 Or-58, Pleasant Hill, OR 97455 Phone: 541-988-7300 |
News Archive
Study reveals non-hip, non-vertebral fractures may also increase risk of death
It is well known that hip and vertebral fractures increase the risk of premature death. Until now, little has been known about the clinical impact of non-hip, non-vertebral fractures - so new Australian research showing that they may also increase the risk of death will better inform treatment.
STAAR Surgical Company reports promising assessments from CAST
STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products today reported that the Collamer Accommodating Study Team (CAST) formed by the company in late 2008 has provided very promising initial patient vision assessments from the first phase of the project.
Experts identify key challenges in youth with neurodevelopmental disabilities
In a study published today by the medical journal Paediatrics & Child Health, IRCM researchers address shortcomings in transitional care in the Canadian healthcare system. The team led by Eric Racine and Emily Bell, Montr-al neuroethics experts, identified important challenges in the transition from paediatric to adult health care, especially among youth with neurodevelopmental disabilities (such as autism spectrum disorders, fetal alcohol spectrum disorders and cerebral palsy).
Teva commences commercial launch of Escitalopram Oxalate Tablets
Teva Pharmaceutical Industries Ltd. announced today that it has commenced commercial launch of Escitalopram Oxalate Tablets, the Company's generic version of Forest Laboratories' depression and generalized anxiety disorder treatment, Lexapro Tablets.
› Verified 6 days ago